MicroRNA-1265 p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk 1

Atherosclerosis, a hyperlipidemia-induced chronic inflammatory process of the arterial wall, develops preferentially at sites where disturbed laminar flow compromises endothelial cell (EC) function. Here we show that endothelial miR-126-5p maintains a proliferative reserve in ECs through suppression of the Notch1 inhibitor delta-like 1 homolog (Dlk1) and thereby prevents atherosclerotic lesion formation. Endothelial recovery after denudation was impaired in Mir126−/− mice because lack of miR-126-5p, but not miR-126-3p, reduced EC proliferation by derepressing ©2014 Nature America, Inc. All rights reserved. Reprints and permissions information is available online at http://www.nature.com/reprints/index.html Correspondence should be addressed to A.S. (aschober@med.lmu.de) or C.W. (chweber@med.lmu.de). 9These authors contributed equally to this work. Accession codes. The microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus database under accession number GSE34262. Note: Any Supplementary Information and Source Data files are available in the online version of the paper. AUTHOR CONTRIBUTIONS A.S. and C.W. designed the study, analyzed data and wrote the paper. M.N.-J. performed mouse experiments and collected and processed the histological and qRT-PCR data. Y. W. collected data and performed luciferase assays and mimic treatments. K.B. performed and analyzed in vitro experiments. F.G. and F.K. collected data and performed the fluorescence molecular tomography and computed tomography analyses. J.G. was involved in the analysis of human atherosclerotic lesions. R.T.M. performed the multiphoton microscopy analysis. K.H. collected data and processed the in situ hybridization and immunostaining data. H.N. performed immunoblots and in vitro experiments. M.H. performed flow cytometry analysis and cell culture experiments under flow conditions. S.W. and E.N.O. were involved in study design and contributed to the mouse experiments. A.S. and M.N.-J. contributed equally to the study. All authors discussed the results and commented on the manuscript. COMPETING FINANCIAL INTERESTS The authors declare no competing financial interests. HHS Public Access Author manuscript Nat Med. Author manuscript; available in PMC 2015 April 15. Published in final edited form as: Nat Med. 2014 April ; 20(4): 368–376. doi:10.1038/nm.3487. A uhor M anscript

[1]  M. V. van Zandvoort,et al.  Endothelial Junctional Adhesion Molecule-A Guides Monocytes Into Flow-Dependent Predilection Sites of Atherosclerosis , 2013, Circulation.

[2]  Daniela Wenzel,et al.  Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles , 2013, Circulation.

[3]  R. Adams,et al.  Notch controls retinal blood vessel maturation and quiescence , 2013, Development.

[4]  A. Schober,et al.  MicroRNAs in flow-dependent vascular remodelling. , 2013, Cardiovascular research.

[5]  Shu Chien,et al.  Regulation of Vascular Smooth Muscle Cell Turnover by Endothelial Cell–Secreted MicroRNA-126: Role of Shear Stress , 2013, Circulation research.

[6]  A. Schober,et al.  MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Zhe Zhang,et al.  Notch1-mediated signaling regulates proliferation of porcine satellite cells (PSCs). , 2013, Cellular signalling.

[8]  Jennifer V. Schmidt,et al.  Conditional deletions refine the embryonic requirement for Dlk1 , 2013, Mechanisms of Development.

[9]  T. Lüscher,et al.  AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. , 2013, Blood.

[10]  Gary D Bader,et al.  Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion , 2012, Cell stem cell.

[11]  F. Kiessling,et al.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. , 2012, The Journal of clinical investigation.

[12]  J. Laborda,et al.  Membrane-Tethered Delta-Like 1 Homolog (DLK1) Restricts Adipose Tissue Size by Inhibiting Preadipocyte Proliferation , 2012, Diabetes.

[13]  Santiago Lamas,et al.  The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. , 2012, Cardiovascular research.

[14]  C. Weber,et al.  Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.

[15]  Fabian Kiessling,et al.  Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography. , 2011, Radiology.

[16]  Kimiko Yamamoto,et al.  Effects of shear stress and stretch on endothelial function. , 2011, Antioxidants & redox signaling.

[17]  M. V. van Zandvoort,et al.  Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. , 2011, Cell metabolism.

[18]  J. Visvader,et al.  Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow. , 2010, Blood.

[19]  AnnaZampetaki,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010 .

[20]  Stefanie Dimmeler,et al.  Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.

[21]  YoshiakiItoh,et al.  Resident Endothelial Cells Surrounding Damaged Arterial Endothelium Reendothelialize the Lesion , 2010 .

[22]  M. Hristov,et al.  Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.

[23]  H. Sul Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. , 2009, Molecular endocrinology.

[24]  C. Stoeckert,et al.  Chronic Endoplasmic Reticulum Stress Activates Unfolded Protein Response in Arterial Endothelium in Regions of Susceptibility to Atherosclerosis , 2009, Circulation research.

[25]  Qingbo Xu,et al.  Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow , 2009, Proceedings of the National Academy of Sciences.

[26]  W. Min,et al.  Mechanisms of endothelial dysfunction, injury, and death. , 2009, Annual review of pathology.

[27]  Thomas D. Schmittgen,et al.  In situ detection of mature microRNAs by labeled extension on ultramer templates. , 2009, BioTechniques.

[28]  K. Stankunas,et al.  Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 , 2008, Development.

[29]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[30]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[31]  Qingbo Xu,et al.  Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E–Deficient Mice , 2008, Circulation.

[32]  Joshua T. Mendell,et al.  MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.

[33]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[34]  William C. Aird,et al.  Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms , 2007, Circulation research.

[35]  N. Voelkel,et al.  Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  V. Baladrón,et al.  dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. , 2005, Experimental cell research.

[37]  A. Schober,et al.  Crucial Role of Stromal Cell–Derived Factor-1&agr; in Neointima Formation After Vascular Injury in Apolipoprotein E–Deficient Mice , 2003, Circulation.

[38]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[39]  G. Chisolm,et al.  Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. , 2001, Trends in cardiovascular medicine.

[40]  Y. T. Lee,et al.  Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. , 2000, Circulation.

[41]  D Kaiser,et al.  Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. , 1997, Biochemical and biophysical research communications.

[42]  L. Nielsen,et al.  Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. , 1996, Atherosclerosis.

[43]  S. Schwartz,et al.  Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. , 1985, The American journal of pathology.

[44]  S. Schwartz,et al.  Aortic endothelial cell replication. I. Effects of age and hypertension in the rat. , 1977, Circulation research.

[45]  H. Wright,et al.  Endothelial Mitosis around Aortic Branches in Normal Guinea-pigs , 1968, Nature.

[46]  YuanyuanWei,et al.  The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis , 2013 .

[47]  ChristianWeber,et al.  CXCL12 Promotes the Stabilization of Atherosclerotic Lesions Mediated by Smooth Muscle Progenitor Cells in Apoe-Deficient Mice , 2013 .

[48]  S. Chien,et al.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.